N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

This study has been withdrawn prior to enrollment.
(No funding was available for the cost of the IV N-acetylcysteine (NAC).)
Sponsor:
Information provided by (Responsible Party):
OHSU Knight Cancer Institute
ClinicalTrials.gov Identifier:
NCT01138137
First received: June 3, 2010
Last updated: April 1, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)